Home › Ventana Companion Diagnostics CAP/CLIA Lab Launches New Robust Prototype Assays
 

Keywords :   


Ventana Companion Diagnostics CAP/CLIA Lab Launches New Robust Prototype Assays

2014-06-04 13:03:18| drugdiscoveryonline News Articles

Ventana Medical Systems, Inc.(Ventana), a member of theRocheGroup, today announced the launch of three new companion diagnostic robust prototype assays (RPAs) for the detection of biomarkers PSMA, MDM2 and FGFR, offering biotech and pharmaceutical companies more options in exploring novel treatment options for patients with cancer

Tags: lab robust companion launches

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
22.11ONE PIECE 1109
22.1190old
22.11SHIMANO
22.11Hi-STANDARD growing up
22.1111th ANNIVERSARY SPECIAL SET
22.11 3
22.11
22.11MSR LIGHTNING ASCENT25
More »